# OnCo record clsp-1025 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/clsp-1025/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "clsp-1025" ;
  schema:name "CLSP-1025"@en ;
  schema:description "CLSP-1025 is an experimental bispecific T cell engager from Clasp Therapeutics, in phase 1 trials for advanced solid tumours with the TP53 R175H mutation."@en ;
  schema:url <https://onco.cc/drugs/clsp-1025/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://www.clasptx.com/press-release-publications/ccr-preclinical-characterization-of-clsp-1025>, <https://www.clasptx.com/press-release-publications/ccr-preclinical-characterization-of-clsp-1025>, <https://clinicaltrials.gov/study/NCT06778863>, <https://clinicaltrials.gov/search?intr=CLSP-1025> ;
  onco:status "phase-1" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "Bispecific T cell engager (half-life extended)" ;
  onco:cancers <https://onco.cc/cancers/metastatic-cancer/> ;
  onco:targets <https://onco.cc/targets/tp53/>, <https://onco.cc/targets/cd3/> ;
  onco:companies <https://onco.cc/companies/clasp-therapeutics/> ;
  onco:trials <https://onco.cc/trials/nct06778863/> .